Literature DB >> 9376139

[Intraoperative infiltration of 0.5% bupivacaine in pediatric tonsillectomy].

M V Alvarez García1, B Santaolalla Fragoso, J Cebrián Pazos, G Aránguez Moreno, M T López Gil, F García Mon.   

Abstract

Twenty-eight healthy pediatric patients scheduled for bilateral tonsillectomy under general anesthesia were allocated randomly into two groups. The same anesthetic technique was used in both groups. After oral intubation, tonsils were infiltrated with either 0.5% bupivacaine (group B) or isotonic saline solution (group F). During surgery, hemodynamic stability, blood loss, and need for additional anesthesia were evaluated. After surgery, hemodynamic stability, pain, general behavior, need for analgesics, oral intake, and complications were evaluated. The bupivacaine group had significantly less bleeding in the first tonsil, less need for anesthetics, and less pain in the first eight hours after surgery. None of the other variables showed statistically significant differences. These results suggest that preoperative infiltration of the tonsils with bupivacaine was useful for reducing bleeding and intraoperative anesthesia requirements, and that it reduced pain in the immediate postoperative period.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9376139

Source DB:  PubMed          Journal:  Acta Otorrinolaringol Esp        ISSN: 0001-6519


  2 in total

1.  Peritonsillar infiltration with tramadol improves pediatric tonsillectomy pain.

Authors:  Ahmed Atef; Ahmed Aly Fawaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-17       Impact factor: 2.503

2.  Preemptive peritonsillar infiltration with bupivacaine in combination with tramadol improves pediatric post-tonsillectomy pain better than using bupivacaine or tramadol alone: A randomized, placebo-controlled, double blind clinical trial.

Authors:  Azim Honarmand; Mohammadreza Safavi; Khosrou Naghibi; Mohammadali Attari; Mojtaba Soltani; Mahsa Amoushahi; Fatemeh Sadeghipanah
Journal:  Adv Biomed Res       Date:  2015-07-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.